Integrated BioPharma, Inc. – Filings and Transcripts

OTC: INBP
Share price (9/1/26): $0.18
Market cap (9/1/26): $5.591 million

Warning: Large portions of this site require JavaScript enabled in order to function properly. Please make sure JavaScript is enabled in your browser.

Please let us know at support@bamsec.com if you have any questions or concerns.

Search in Documents

Key Exhibits

External Links

Financials Filter

ended 03/31/26 Q3

ended 12/31/25 Q2

ended 09/30/25 Q1

ended 06/30/25 FY 2025

ended 03/31/25 Q3

Prospectuses and Registrations Filter

Registration of securities for employees

Exempt offering of securities

Removal from listing

Prospectus supplement

Shelf registration – amended

Ownership Filter

Milmoe William H.

Canarick Robert

Friedman Eric J

Friedman Eric J

News Filter

Wholly-Owned Subsidiary, Manhattan Drug Company, Inc. Appoints Michael Richtmyer as Head of Operations

Material Definitive Agreement, Termination of Material Definitive Agreement, Financial Statements or Exhibits

Reports Results for Its Quarter Ended March 31, 2026

Other Events, Financial Statements or Exhibits

Material Definitive Agreement, Financial Statements or Exhibits

Proxies Filter

Definitive proxy

Definitive proxy

Definitive proxy

Definitive proxy

Definitive proxy

Other Filter

Scanned paper annual report submission

Letter from the SEC

Notice of effectiveness

Correspondence with the SEC

Letter from the SEC